This company listing is no longer active
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Genertec Universal Medical Group Crescita futura
Future criteri di controllo 2/6
Genertec Universal Medical Group is forecast to grow earnings and revenue by 10.8% and 11.1% per annum respectively while EPS is expected to grow by 7.8% per annum.
Informazioni chiave
10.8%
Tasso di crescita degli utili
7.8%
Tasso di crescita dell'EPS
| Diversified Financial crescita degli utili | 1.7% |
| Tasso di crescita dei ricavi | 11.1% |
| Rendimento futuro del capitale proprio | n/a |
| Copertura analitica | Low |
| Ultimo aggiornamento | 02 Apr 2023 |
Aggiornamenti recenti sulla crescita futura
Nessun aggiornamento
Recent updates
Previsioni di crescita degli utili e dei ricavi
| Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
|---|---|---|---|---|---|
| 12/31/2025 | 16,267 | 2,612 | 4,764 | 4,923 | 2 |
| 12/31/2024 | 14,753 | 2,497 | 3,699 | 4,081 | 3 |
| 12/31/2023 | 13,354 | 2,354 | 1,608 | 3,254 | 3 |
| 12/31/2022 | 11,566 | 1,890 | 1,449 | 2,057 | N/A |
| 9/30/2022 | 10,935 | 1,882 | 1,186 | 1,695 | N/A |
| 6/30/2022 | 10,305 | 1,875 | 923 | 1,333 | N/A |
| 3/31/2022 | 9,936 | 1,855 | -431 | -34 | N/A |
| 12/31/2021 | 9,567 | 1,835 | -1,786 | -1,401 | N/A |
| 9/30/2021 | 9,371 | 1,870 | -3,883 | -3,520 | N/A |
| 6/30/2021 | 9,175 | 1,904 | -5,980 | -5,640 | N/A |
| 3/31/2021 | 8,709 | 1,776 | -3,676 | -3,306 | N/A |
| 12/31/2020 | 8,243 | 1,648 | -1,373 | -972 | N/A |
| 9/30/2020 | 7,843 | 1,559 | 848 | 1,212 | N/A |
| 6/30/2020 | 7,444 | 1,470 | 3,070 | 3,397 | N/A |
| 3/31/2020 | 7,095 | 1,479 | 519 | 786 | N/A |
| 12/31/2019 | 6,747 | 1,489 | -2,032 | -1,824 | N/A |
| 9/30/2019 | 6,071 | 1,459 | -4,512 | -4,367 | N/A |
| 6/30/2019 | 5,395 | 1,429 | -6,991 | -6,909 | N/A |
| 3/31/2019 | 4,845 | 1,390 | -6,369 | -6,319 | N/A |
| 12/31/2018 | 4,295 | 1,352 | -5,746 | -5,729 | N/A |
| 9/30/2018 | 4,080 | 1,329 | -6,215 | -6,198 | N/A |
| 6/30/2018 | 3,865 | 1,305 | -6,683 | -6,667 | N/A |
| 3/31/2018 | 3,645 | 1,227 | -5,887 | -5,870 | N/A |
| 12/31/2017 | 3,424 | 1,149 | -5,091 | -5,072 | N/A |
| 9/30/2017 | 3,267 | 1,105 | -4,422 | -4,400 | N/A |
| 6/30/2017 | 3,111 | 1,062 | -3,754 | -3,729 | N/A |
| 3/31/2017 | 2,910 | 967 | -3,078 | -3,055 | N/A |
| 12/31/2016 | 2,709 | 872 | -2,402 | -2,382 | N/A |
| 9/30/2016 | 2,587 | 825 | N/A | -2,577 | N/A |
| 6/30/2016 | 2,464 | 778 | N/A | -2,773 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: UMTA.F's forecast earnings growth (10.8% per year) is above the savings rate (2.1%).
Guadagni vs Mercato: UMTA.F's earnings (10.8% per year) are forecast to grow slower than the US market (14.9% per year).
Guadagni ad alta crescita: UMTA.F's earnings are forecast to grow, but not significantly.
Ricavi vs Mercato: UMTA.F's revenue (11.1% per year) is forecast to grow faster than the US market (8.1% per year).
Ricavi ad alta crescita: UMTA.F's revenue (11.1% per year) is forecast to grow slower than 20% per year.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: Insufficient data to determine if UMTA.F's Return on Equity is forecast to be high in 3 years time